Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of DTPw-HBV/Hib Vaccines in Infants
NCT00316680Phase 3Terminated
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of DTwP-HepB-Hib vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Mar 2006; status: terminated.
02
Drugs
DTwP-HepB-Hib vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00316680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316680.